C. Lees

Risk of thrombosis with thrombocytopenia syndrome after COVID‐19 vaccination prior to the recognition of vaccine‐induced thrombocytopenia and thrombosis: A self‐controlled case series study in England

C. Atchison, M. Ramsay, S. Booth, 2022, Research and Practice in Thrombosis and Haemostasis.

Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions

M. Gandhi, J. Gunawardana, C. Keane, 2019, British journal of haematology.

Host Genetic Mutations and Expression Analyses in PTLD

M. Gandhi, C. Lees, 2021 .

Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients

K. Ramasamy, André Gomes, F. Djebbari, 2022, PloS one.

Efficacy and tolerability of VCD chemotherapy in a UK real‐world dataset of elderly transplant‐ineligible newly diagnosed myeloma patients

K. Ramasamy, F. Djebbari, T. Eyre, 2021, European Journal of Haematology.

Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib

S. Booth, T. Sage, J. Gibbins, 2022, Haematologica.